Table 2.
Response of Patients with Metastatic Cancer Treated Using High-Dose Bolus Interleukin-2
| n (%) | ||||
|---|---|---|---|---|
| Diagnosis | Total n | Complete regression | Partial regression | Complete regression + partial regression |
| Melanoma | 182 | 12 (7) | 16 (9) | 28 (15) |
| Renal cell cancer | 227 | 21 (9) | 22 (10) | 43 (19) |
| Total | 409 | 33 (8) | 38 (9) | 71 (17) |
Patients accrued between September 1985 and November 1996.
Followup as of June 1, 2003 (median followup 11.9 y).